What is operator-led advisory in private equity?

Operator-led advisory means the people advising have held operating accountability inside portfolio companies rather than only analyzing them. The practical difference appears in diligence: execution risk, organizational capacity to absorb change, and whether a plan survives contact with the people who have to run it.

How does an operator-led advisor differ from a management consultant?

A consultant is trained to reach the right answer analytically. An operator has been accountable for delivering one. Firms searching for private equity investment consultants often want the second and hire the first. Both have value. The distinction matters most when execution risk, rather than market structure, is the open question.

What does private equity portfolio optimization involve?

Margin expansion through operational change, working capital release through cash conversion and inventory discipline, and transferring what works in one portfolio company to others. Each initiative should tie to a fund-level metric. Improvements that never reach IRR or MOIC do not count as portfolio optimization.

How should a GP choose among advisory firms for portfolio optimization?

Ask whether anyone on the team has held operating accountability, what their decline rate is, whether the people pitching will do the work, and whether they operate in your deal size. A firm built for $2bn carve-outs will apply that machinery to a $150m platform and charge accordingly.

What is reverse due diligence?

The term carries two meanings. In an exit context it means diligencing your own asset the way a buyer will, so objections surface internally before the process starts. Separately, GPs use it for diligence on prospective LPs, covering capital reliability, default risk and reputational exposure. The two are unrelated exercises.

Do you work with venture capital firms as well as private equity?

Yes. The underlying question is the same, though the metrics differ. For venture holdings the work centers on unit economics, scaling discipline and technical validation rather than EBITDA and margin. Diligence work spans both.

Operator-Led Private Equity & Venture Capital Advisory for GPs and LPs

Creating Value Across the Investment Lifecycle

Capital costs more than it did three years ago and the margin for error in a mid-market deal has narrowed. The traditional lever, financial engineering (leverage, multiple arbitrages, refinancing), stopped being enough on its own some time ago. IPO windows remain tight and the secondary market has also become more selective.

Arete Ventures works only with the buy side: GPs, LPs, family offices and institutional investors across the US, UK, EU and UAE. Our focus is mid-market, because that is where the gap between a good thesis and a realized return is usually operational rather than analytical.

Our background is fifteen years as an operating partner at a San Francisco private equity firm, across technology and clean energy portfolio companies. We have carried plans we did not write, in companies we did not build.

Private Equity and Venture Capital Portfolio Optimization

"Value creation is measured in EBITDA, growth, and lasting operational excellence."

Two asset classes, two failure modes. What they share is that the binding constraint is almost never the one named in the investment memo.

Where capital structure rather than operations is that constraint, it is a different diagnosis. We cover the method in capital stack diagnostics.

For Private Equity Firms

Portfolio optimization in the mid-market is a sequencing problem. Which constraint gets addressed first, in what order, and whether the organization can absorb the change while still running the business.

Our work covers margin expansion through operational change rather than pricing alone, working capital release through cash conversion cycle and inventory discipline, and portfolio-wide transfer where something proven in one company applies to two or three others. Every initiative ties back to a fund-level metric. A portfolio company improvement that never shows up in IRR or MOIC is a hobby.

Venture Capital Strategy Consulting for VC Firms

Venture portfolios fail differently. The constraint is rarely margin. It is whether a company can survive the transition from growth funded by capital to growth funded by its own economics, and whether the fund can tell which of its companies are close to that line.

For VC firms, growth strategy consultants are best when they can connect portfolio-company operating decisions directly to fund-level outcomes. Our VC portfolio optimization focuses on unit economics that hold at scale rather than at current volume, go-to-market motions that can be staffed and repeated rather than carried by two founders, the timing judgment that decides most Series B outcomes and when to stop optimizing for growth rate and start optimizing for capital efficiency.

For platform teams supporting twenty or more companies, the practical problem is triage. Which three companies justify partner time this quarter, and on what evidence.

Post-Close Integration &
Value Capture

"Deals lose value in the two quarters after close more often than in the diligence that preceded them."

Integration is where an investment thesis either becomes an operating reality or quietly stops being true.

Where integration extends into a wider buy-and-build program, our Buy-Side M&A Advisory covers the transaction side. Where the work continues into sustained operating change, that sits with our Performance Improvement Advisory.

We build post-acquisition integration plans for cross-border transactions, technology acquisitions carrying IP complexity, and bolt-ons into a platform that is still growing.

The first hundred days set the ceiling for the rest of the hold. What gets decided in that window is which systems survive, who reports to whom, and whether each synergy in the model has an owner with a date against it.

The failure mode is consistent enough to predict. Synergy models assume two sales organizations will cross-sell when they have incompatible incentives, incompatible systems, and no particular reason to cooperate. We put that in the model rather than discovering it in month seven.

When an integration is running behind, the first question is rarely about the plan. It is whether anyone has been given the authority to make the calls the plan requires.

Preparing Portfolio Companies for Premium Exits

"Exits are campaigns. They start eighteen to twenty-four months before anyone is told."

Most exit processes begin too late to change anything that matters. By the time a bank is appointed, the reporting, the governance and the customer concentration are what they are.

Exit readiness work is unglamorous: financial hygiene, governance, KPI discipline, and a buyer narrative that survives a hostile read.

Reverse due diligence is the core of it. We diligence the asset the way the buyer's team will, so their objections surface in your process rather than three weeks before signing. A note on terminology, since the phrase is used two ways in the market: here it means sell-side preparation, not the separate practice of GPs diligencing prospective LPs.

What comes out of it is a list with dates against it. Some items are fixable in a quarter. Some take a year, which is exactly why the work starts early. And some are not fixable at all, in which case the useful outcome is knowing the discount before the buyer names it.

A note on terminology, since the phrase is used two ways in the market: here it means sell-side preparation, not the separate practice of GPs diligencing prospective LPs.

Frontier Sector Technical Due Diligence

"In frontier sectors the financial model sits downstream of a technical question most diligence never asks."

Hype cycles, regulatory uncertainty and genuine technical complexity make it hard to tell a breakthrough from a well-funded experiment.

The method is set out in our frontier tech diligence playbook.

Key Frontier Technologies

Agentic AI and applied machine learning. Which pilots converted to paid production, at what contract value, and how much of the stack the company built rather than wrapped around a frontier model it does not control.
Quantum and edge computing. What logical error rate the claimed application actually requires, and how far current hardware sits from it. Companies leading with physical qubit counts are usually answering a different question.
Advanced life sciences and biotech. The largest vessel the organism has run in, what happened to titer, rate and yield at that scale, and what downstream separation costs. Recovery often runs over half of COGS and is routinely absent from the model.
Climate tech and energy transition. SAF, green hydrogen, PtL, AtJ, cellulosic biofuels and carbon removal. Whether offtake is binding, whether the company qualifies today under IRA or RED III, and what the certification pathway costs.

What we test

Whether the claimed technical milestone is the one that actually gates revenue, or a milestone that is easier to reach and easier to announce.
Where the IP came from, what is genuinely proprietary, and how far it sits from replication by someone with a larger budget.
Whether the founding team has industrial scale-up experience or only research depth. This is the most common structural gap in the asset class and the hardest to fix after close.
Whether the technical appendix and the financial model use the same assumptions. They frequently do not, and that gap is where most of the value at risk sits.

Across nine buy-side diligence engagements we advised against proceeding on three. In each case the technology worked. What did not survive was the timeline attached to it.

Principles That Shape Our Work

Twenty years on the buy side, since 2006. Gaurav Shah spent fifteen of those as an operating partner at a San Francisco private equity firm. Nine buy-side diligence engagements, $60M to $575M in enterprise value. Seven in manufacturing and industrials, two in enterprise technology. Seven US, one UK, one EU.

We advised against proceeding on three of the nine.

What we find repeatedly

Manufacturing and industrials

Phantom capacity. Management reports 80% utilization. Net out changeover time, unplanned downtime and labor gaps and the real number is often fifteen to twenty points lower. The growth plan was built on the reported figure.
Deferred maintenance carried as EBITDA. Servicing skipped during the hold reads as margin improvement and transfers to the next owner as a capital liability.
Capital in the wrong place. New equipment bought while the actual bottleneck sits two stations upstream, untouched.
Revenue resting on letters of intent. Pipelines built on non-binding LOIs rather than take-or-pay contracts, often alongside a single legacy customer at 40% or more of revenue with no long-term protection.

Enterprise technology

Churn hidden behind net revenue retention. Dollar-based NRR looks healthy while unit churn climbs, because expansion in a handful of large accounts masks losses across the base.
Capitalized R&D. Routine maintenance work moved onto the balance sheet as development, improving reported EBITDA without changing anything real.
Architecture assembled from bolt-ons. Four acquisitions, four stacks, no integration, and no path to scale without a rewrite nobody has budgeted.
Key-person product risk. The system depends on one or two long-tenured engineers who hold the architecture in their heads and have never written it down.

Across both

Inventory bloat from overproducing to improve per-unit cost, tying up cash and aging stock.
Extended DSO from generous payment terms used to hit revenue targets, which quietly damages the cash conversion cycle.
Synergy models assuming cultural compatibility between organizations that have none.

Two Engagements

US industrial manufacturer, mid-market. The sponsor's growth thesis rested on capacity that did not exist. Reported utilization was 80%. Netted properly it was closer to 62%. The revised plan put capital into the real constraint rather than the new line management had been requesting, and the working capital work released $6.2M by compressing inventory days and the cash conversion cycle, taking the business off its asset-based revolver. Margin improved roughly four points across the hold. The sponsor executed; we scoped the work and stayed through the first two quarters. What took longest was not the operations work at all. Getting a management team to accept that a number they had reported for three years was wrong took most of a quarter.

US B2B software platform. Four bolt-ons, four architectures, no way to scale without consolidation. We recommended the sponsor extend the hold by six months rather than take the exit window that was open. That recommendation cost IRR in the near term and was not welcome in the room. Consolidating onto a single platform moved transactional revenue toward recurring, and sunsetting duplicate cloud infrastructure and vendor spend took $3.8M of annualized cost out within two quarters. The asset exited materially above its pre-extension mark. Whether that delta justified the six months is still an open argument between us and the sponsor.

Frequently Asked Questions (FAQs)

Operator-led advisory means the people advising have held operating accountability inside portfolio companies rather than only analyzing them. The practical difference appears in diligence: execution risk, organizational capacity to absorb change, and whether a plan survives contact with the people who have to run it.
A consultant is trained to reach the right answer analytically. An operator has been accountable for delivering one. Firms searching for private equity investment consultants often want the second and hire the first. Both have value. The distinction matters most when execution risk, rather than market structure, is the open question.
Margin expansion through operational change, working capital release through cash conversion and inventory discipline, and transferring what works in one portfolio company to others. Each initiative should tie to a fund-level metric. Improvements that never reach IRR or MOIC do not count as portfolio optimization.
Ask whether anyone on the team has held operating accountability, what their decline rate is, whether the people pitching will do the work, and whether they operate in your deal size. A firm built for $2bn carve-outs will apply that machinery to a $150m platform and charge accordingly.
The term carries two meanings. In an exit context it means diligencing your own asset the way a buyer will, so objections surface internally before the process starts. Separately, GPs use it for diligence on prospective LPs, covering capital reliability, default risk and reputational exposure. The two are unrelated exercises.
Yes. The underlying question is the same, though the metrics differ. For venture holdings the work centers on unit economics, scaling discipline and technical validation rather than EBITDA and margin. Diligence work spans both.